Biocon Limited — Updates, 27-01-2025: Press Release

Biocon Limited has reported a significant improvement in its Environmental, Social and Governance (ESG) scores for 2024, achieving a score of 69, which is a rise of 6 points from 63 in 2023. This places Biocon in the 98th percentile among global biotechnology peers, with scores of 76 in the Environmental Dimension, 74 in the Social Dimension, and 62 in Governance. Additionally, its subsidiary, Biocon Biologics, debuted with an ESG score of 53 in its first independent assessment. The enhanced scores reflect Biocon’s commitment to sustainability, with strategic efforts focused on reducing GHG emissions and freshwater consumption while improving waste management practices. Transparency remains a priority, with 90% of required disclosures made available to S&P Global. The company's robust ESG governance structure positions it for continued performance advancement, aligning with positive long-term growth.